Last reviewed · How we verify

NCT02057081: MFG-mTBI

Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI

Completed NA Results posted Last updated 4 June 2020
What this trial tests

NA trial testing Multifamily Group for mTBI for Couples in Mild Traumatic Brain Injury in 249 participants. Completed in 31 August 2019.

Timeline
9 October 2014
Primary endpoint
12 March 2019
31 August 2019

Quick facts

Lead sponsorVA Office of Research and Development
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment249
Start date9 October 2014
Primary completion12 March 2019
Estimated completion31 August 2019
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

VA Office of Research and Development — full company profile →

Who can join

Adults 18 to 65, any sex, with Mild Traumatic Brain Injury or Posttraumatic Stress Disorders. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Change in the Community Reintegration of Injured Service Members Computer Adaptive Test (CRIS-CAT) Primary · baseline, post-treatment in study month 38 after 12 bimonthly sessions, and 6-months post-treatment in study month 44

The Community Reintegration of Injured Service Members Computer Adaptive Test (CRIS-CAT) was used to measure community reintegration. The measure includes 3 subscales: Extent of Participation, Perceived Limitations, and Satisfaction. A total score for each subscale is calculated by summing item responses (range= 10 to 140), with higher scores indicating greater frequency of community participation (extent of participation), greater perceived limitations to community participation (perceived limitations), and greater satisfaction with community participation (satisfaction).

Baseline: Extent of Participation Subscale
GroupValue95% CI
Treatment36.4± 7.8
Control35.0± 5.4
Post-Treatment: Extent of Participation Subscale
GroupValue95% CI
Treatment38.2± 6.4
Control35.1± 6.1
6-Month Follow-Up: Extent of Participation Subscal
GroupValue95% CI
Treatment37.6± 7.9
Control38.0± 6.5
Baseline: Perceived Limitations Subscale
GroupValue95% CI
Treatment41.0± 4.9
Control41.0± 4.9
Post-Treatment: Perceived Limitations Subscale
GroupValue95% CI
Treatment41.7± 5.1
Control41.3± 4.8
6-Month Follow-Up: Perceived Limitations Subscale
GroupValue95% CI
Treatment41.1± 4.7
Control42.3± 4.5
Baseline: Satisfaction Subscale
GroupValue95% CI
Treatment39.8± 6.0
Control39.9± 4.5
Post-Treatment: Satisfaction Subscale
GroupValue95% CI
Treatment41.0± 5.7
Control40.3± 4.7
Change in Caregiver Burden Inventory Secondary · Baseline, post-treatment in study month 38 after 12 bimonthly sessions, and 6-months post-treatment in study month 44

The Caregiver Burden Inventory is a 24-item scale that measures caregiver burden in four areas: physical, social, emotional and time dependence burden. A total score is calculated by summing the item responses (range= 1 to 100), with higher scores indicating greater caregiver burden.

Baseline
GroupValue95% CI
Treatment24.9± 20.0
Control25.8± 16.5
Post-treatment
GroupValue95% CI
Treatment24.8± 22.3
Control25.6± 15.0
6-month Post-Treatment
GroupValue95% CI
Treatment21.5± 19.0
Control27.1± 20.1

Adverse events — posted to ClinicalTrials.gov

Time frame: Duration of participants involvement in the study, up to ~ 16 months. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Treatment
Serious: 6/136 (4%)
Deaths: 0/136
Control
Serious: 4/112 (4%)
Deaths: 0/112

Serious adverse events (6 terms)

ReactionSystemTreatmentControl
self-reported interpersonal violenceSocial circumstances
psychiatric hospitalizationPsychiatric disorders
medical hospitalizationSurgical and medical procedures
Medical hospitalizationPregnancy, puerperium and perinatal conditions
Medical hospitalizationRespiratory, thoracic and mediastinal disorders
Medical hospitalizationImmune system disorders

Most-reported serious reactions: self-reported interpersonal violence, psychiatric hospitalization, medical hospitalization, Medical hospitalization, Medical hospitalization, Medical hospitalization.

Data from ClinicalTrials.gov NCT02057081 adverse events section.

Sponsor's own description

This project addresses the rehabilitation and mental health needs of married combat Veterans post-deployed from Iraq or Afghanistan with a mild traumatic brain injury (mTBI) and/or significant posttraumatic stress (PTS) or combat-related stress (CS) by providing psychoeducation, communication and problem solving skills in a multifamily group (MFG) setting. In this group, Veterans and spouses/cohabiting partners learn customized therapeutic strategies to help compensate for deficits and promote Veteran community integration, interpersonal and emotion regulation skills, and marital satisfaction. The effectiveness of the skills-based MFG will be compared to that of a health education group which offers a supportive environment and basic education without skills training through a randomized clinical trial. As there is currently no family-based intervention for Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans with mTBI offered within the VA spectrum of services, this intervention fills a crucial gap in healthcare for our newest Veterans.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mild Traumatic Brain Injury

Currently open trials in the same condition.

Other VA Office of Research and Development trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02057081.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing